Search CDMOs

• AAV Manufacturing
• CMC Analytical Development
• Cell Therapy Manufacturing

Global viral vector CDMO with 30 years of expertise in lentivirus, AAV, and adenovirus manufacturing. Provides end-to-end development and GMP-compliant manufacturing services from preclinical through commercial launch for cell and gene therapy programs.

• AAV Manufacturing
• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development

Global CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities.

• AAV Manufacturing
• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development

Global CDMO providing end-to-end contract development and manufacturing for pharma, biotech, and consumer health. Delivers 60+ billion doses annually across small molecules, biologics, cell & gene therapies, and clinical supply.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

Global leader in peptide and oligonucleotide development and manufacturing, offering GMP-compliant clinical and commercial supply from early research through commercial scale.

• CMC Analytical Development
• CMC Regulatory Submission Support
• mRNA Manufacturing

Global CDMO leader in nucleic acid manufacturing and analysis (mRNA, ASO, siRNA, guide RNA, oligonucleotides) with nearly three decades of expertise, GMP certification since 2007, and support for 9 commercial programs across all clinical phases.

• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development
• Bioconjugation Services

Global CDMO offering end-to-end development and GMP manufacturing for monoclonal antibodies, bispecific antibodies, fusion proteins, recombinant proteins, and antibody-drug conjugates, with facilities in Suzhou and Hangzhou featuring up to 20,000-liter bioreactors.

• CMC Analytical Development
• Biologics Development & Manufacturing
• Cell-Line Development

Global CDMO specializing in cost-effective biologics and biosimilars manufacturing using patented continuous bioprocess technology (EnzeneX®). Offers integrated drug discovery, development, and manufacturing services with facilities in India and expanding presence in the USA and Europe.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

Patheon is a trusted global contract development and manufacturing organization (CDMO) partner owned by Thermo Fisher Scientific, offering 360° integrated solutions from early-stage R&D through clinical supply and commercial manufacturing.

• ADC (Antibody-Drug Conjugate) Manufacturing
• ADC Payload & Linker Synthesis
• CMC Analytical Development

Global CDMO and API manufacturer specializing in complex small molecule development, ADC manufacturing, HPAPIs, and hazardous chemistry across ten production sites in Europe, India, and the US.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

Global CDMO and specialty ingredients manufacturer with 16 production sites and 9 R&D centres offering custom development and GMP manufacturing of pharmaceutical APIs, intermediates, and specialty chemicals from preclinical to commercial scale.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Cartridge Filling

Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

Global CDMO with 16 production sites across four continents, offering integrated development and manufacturing from early-phase to commercial scale for drug substance and drug product.

• Allogeneic Cell Therapy Manufacturing
• CMC Analytical Development
• Autologous Cell Therapy Manufacturing

Cellares operates a global network of Smart Factories delivering integrated development and manufacturing (IDMO) services for cell therapies, with proprietary Cell Shuttle® and Cell Q™ platforms enabling cGMP-compliant, automated manufacturing and quality control at clinical and commercial scale.

• CMC Analytical Development
• CMC Regulatory Submission Support
• Combination Product Assembly & Final Packaging

Global pharmaceutical manufacturer with robust quality systems aligned to US FDA, UK MHRA, and EU GMP standards; operates diversified manufacturing across generics, complex formulations, and specialty segments with advanced automation and digital quality infrastructure.

• CMC Analytical Development
• API Synthesis & Manufacturing
• CMC Regulatory Submission Support

Specialized global CDMO for peptide-based active pharmaceutical ingredients, supporting development and manufacturing of proprietary and generic APIs with expertise in peptide synthesis and GMP manufacturing.

• CMC Analytical Development
• Biologics Development & Manufacturing
• Cell-Line Development

Global CDMO offering cell line development, process development, analytical services, and cGMP clinical and commercial manufacturing for biologics including monoclonal antibodies and recombinant proteins.

• CMC Analytical Development
• API Synthesis & Manufacturing
• Biologics Development & Manufacturing

Global CDMO with 30+ years of experience offering integrated services across small molecule, generic APIs, sterile drug product, and biologics manufacturing, backed by 20+ facilities and 3,000+ professionals across North America, Europe, and India.

• ADC (Antibody-Drug Conjugate) Manufacturing
• CMC Analytical Development
• Biologics Development & Manufacturing

Ajinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service.